Ramadhar Anishka, Miller Phoebe N, Muchengeti Mazvita, Kagura Juliana, Chu Kathryn, Gaskill Cameron
Division of Epidemiology and Biostatistics, School of Public Health, University of the Witwatersrand, Johannesburg, South Africa.
University of California San Francisco, San Francisco, CA, USA.
Ecancermedicalscience. 2024 Mar 7;18:1680. doi: 10.3332/ecancer.2024.1680. eCollection 2024.
Gastric cancer (GC) is the third leading cause of global cancer-related mortality. Despite the shifting burden of GC to low-and middle-income countries, the data regarding incidence, treatment, and outcomes in these settings are sparse. The primary aim of this systematic review was to aggregate all available data on GC in sub-Saharan Africa (SSA) to describe the variability in incidence across the region.
Studies reporting population-based primary data on GC in SSA were considered. The inclusion was limited to primary studies published between January 1995 and March 2022 which comprised of adult patients in SSA with GC. Studies without accessible full text in either French or English language were excluded. Unadjusted GC incidence rates with their standard errors for each study were recalculated from the crude numerators and denominators provided in individual studies.
A total of 5,626 articles were identified in the initial search, of which, 69 studies were retained. Reported incidence rates ranged from a high of 5.56 GC cases per 100,000 in Greater Meru Kenya to a low of 0.04 GC cases per 100,000 people in Benin City Nigeria. The overall crude pooled incidence was 1.20 GC cases per 100, 000 (95%CI 1.15-1.26) with a variability of 99.83% ( < 0.001). From the 29 high-quality population-based registry studies the crude pooled incidence was 1.71 GC cases per 100,000 people (95%CI 1.56-21.88) with a variability of 99.60%.
This systemic review demonstrates that GC incidence is highly variable across SSA. The limited data on GC treatment, mortality, and survival presents a significant challenge to providing a complete epidemiologic description of the burden of GC in SSA. There is a need for further robust data collection, exploration, and research studies on cancer care in SSA, with continued assessment of primary data availability.
胃癌(GC)是全球癌症相关死亡的第三大主要原因。尽管胃癌负担已向低收入和中等收入国家转移,但这些地区关于发病率、治疗和结局的数据却很稀少。本系统评价的主要目的是汇总撒哈拉以南非洲(SSA)所有关于胃癌的可用数据,以描述该地区发病率的变异性。
纳入报告了SSA地区基于人群的胃癌原始数据的研究。纳入范围限于1995年1月至2022年3月发表的原始研究,这些研究包括SSA地区患有胃癌的成年患者。排除无法获取法语或英语全文的研究。根据各研究提供的原始分子和分母,重新计算每项研究未经调整的胃癌发病率及其标准误。
在初步检索中总共识别出5626篇文章,其中69项研究被保留。报告的发病率范围从肯尼亚大梅鲁地区每10万人中高达5.56例胃癌病例到尼日利亚贝宁城每10万人中低至0.04例胃癌病例。总体粗合并发病率为每10万人1.20例胃癌病例(95%CI 1.15 - 1.26),变异性为99.83%(P < 0.001)。在29项高质量的基于人群的登记研究中,粗合并发病率为每10万人1.71例胃癌病例(95%CI 1.56 - 21.88),变异性为99.60%。
本系统评价表明,SSA地区的胃癌发病率差异很大。关于胃癌治疗、死亡率和生存率的有限数据,对全面描述SSA地区胃癌负担的流行病学构成了重大挑战。需要在SSA地区进一步进行有力的数据收集、探索和癌症护理研究,并持续评估原始数据的可获得性。